Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1980 Sep-Oct;53(5):367–384.

Initiation and promotion in cancer formation: the importance of studies on intercellular communication.

V R Potter
PMCID: PMC2595915  PMID: 7013284

Abstract

Three major theories of cancer--somatic mutation, virus causation, and faulty differentiation--are proposed to involve alterations in DNA structure. Each results finally in terms of failures in the normal intercellular communication that involves feedback between differentiated cells acting on less differentiated cells still capable of proliferation. The historical background of the latter idea is traced to Osgood, Weiss and Kavanau, and to Iversen. The historical background of concepts of initiation and promotion are traced to Berenblum and Mottram and the Boutwell concept of promotion as gene activation is cited. It is proposed that gene activation by promoters is a valid concept and that it results from the blocking of the normal intercellular communication postulated by Osgood and others. The problem of explaining the low probability of cancer following initiators or promoters acting alone is cited as a problem in basic science. A hypothesis to solve the problem is proposed: Cancer results from two of more relevant mutations: promoters enhance proliferation of cells with one relevant mutation, thereby increasing the probability of obtaining a cell with two relevant mutations. A new scheme of five stages of hepatocarcinogenesis is proposed in terms of the hypothesis and available data.

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUERBACH O., STOUT A. P., HAMMOND E. C., GARFINKEL L. Changes in bronchial epithelium in relation to sex, age, residence, smoking and pneumonia. N Engl J Med. 1962 Jul 19;267:111–119. doi: 10.1056/NEJM196207192670301. [DOI] [PubMed] [Google Scholar]
  2. Albert R. E., Burns F. J., Bilger L., Gardner D., Troll W. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction. Cancer Res. 1972 Oct;32(10):2172–2177. [PubMed] [Google Scholar]
  3. BERENBLUM I., HARAN N. The initiating action of ethyl carbamate (urethane) on mouse skin. Br J Cancer. 1955 Sep;9(3):453–456. doi: 10.1038/bjc.1955.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bell G. I. Models of carcinogenesis as an escape from mitotic inhibitors. Science. 1976 May 7;192(4239):569–572. doi: 10.1126/science.130679. [DOI] [PubMed] [Google Scholar]
  5. Boutwell R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol. 1974 Jan;2(4):419–443. doi: 10.3109/10408447309025704. [DOI] [PubMed] [Google Scholar]
  6. Butcher F. R., Scott D. F., Potter V. R., Morris H. P. Endocrine control of cyclic adenosine 3',5'-monophosphate levels in several Morris hepatomas. Cancer Res. 1972 Oct;32(10):2135–2140. [PubMed] [Google Scholar]
  7. FISHER B., FISHER E. R. Experimental evidence in support of the dormant tumor cell. Science. 1959 Oct 9;130(3380):918–919. doi: 10.1126/science.130.3380.918. [DOI] [PubMed] [Google Scholar]
  8. Friedewald W. F., Rous P. THE INITIATING AND PROMOTING ELEMENTS IN TUMOR PRODUCTION : AN ANALYSIS OF THE EFFECTS OF TAR, BENZPYRENE, AND METHYLCHOLANTHRENE ON RABBIT SKIN. J Exp Med. 1944 Aug 1;80(2):101–126. doi: 10.1084/jem.80.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hammond E. C. Prospects in cancer epidemiology, and a theory on carcinogenesis. Environ Res. 1967 Jun;1(1):102–113. doi: 10.1016/0013-9351(67)90007-2. [DOI] [PubMed] [Google Scholar]
  10. Hirota N., Williams G. M. Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure. J Natl Cancer Inst. 1979 Nov;63(5):1257–1265. [PubMed] [Google Scholar]
  11. Houck J. C. General introduction to the chalone concept. Natl Cancer Inst Monogr. 1973 Jul;38:1–4. [PubMed] [Google Scholar]
  12. KENNAWAY E. The identification of a carcinogenic compound in coal-tar. Br Med J. 1955 Sep 24;2(4942):749–752. doi: 10.1136/bmj.2.4942.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kalengayi M. M., Ronchi G., Desmet V. J. Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst. 1975 Sep;55(3):579–588. doi: 10.1093/jnci/55.3.579. [DOI] [PubMed] [Google Scholar]
  14. Knudson A. G., Jr, Hethcote H. W., Brown B. W. Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5116–5120. doi: 10.1073/pnas.72.12.5116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kolata G. B. Genes and cancer: the story of Wilms tumor. Science. 1980 Feb 29;207(4434):970–971. doi: 10.1126/science.6243422. [DOI] [PubMed] [Google Scholar]
  16. Kolata G. B. Testing for cancer risk. Science. 1980 Feb 29;207(4434):967–969. doi: 10.1126/science.6243421. [DOI] [PubMed] [Google Scholar]
  17. Miller J. A. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. Cancer Res. 1970 Mar;30(3):559–576. [PubMed] [Google Scholar]
  18. Murray A. W., Fitzgerald D. J. Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells. Biochem Biophys Res Commun. 1979 Nov 28;91(2):395–401. doi: 10.1016/0006-291x(79)91535-3. [DOI] [PubMed] [Google Scholar]
  19. Nadal C. Control of liver growth by growth inhibitors (chalones). Arch Toxicol Suppl. 1979;(2):131–142. doi: 10.1007/978-3-642-67265-1_11. [DOI] [PubMed] [Google Scholar]
  20. OSGOOD E. E. A unifying concept of the etiology of the leukemias, lymphomas, and cancers. J Natl Cancer Inst. 1957 Feb;18(2):155–166. [PubMed] [Google Scholar]
  21. Ogawa K., Solt D. B., Farber E. Phenotypic diversity as an early property of putative preneoplastic hepatocyte populations in liver carcinogenesis. Cancer Res. 1980 Mar;40(3):725–733. [PubMed] [Google Scholar]
  22. Peraino C., Fry R. J., Staffeldt E., Kisieleski W. E. Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 1973 Nov;33(11):2701–2705. [PubMed] [Google Scholar]
  23. Peraino C., Staffeldt E. F., Haugen D. A., Lombard L. S., Stevens F. J., Fry R. J. Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 1980 Sep;40(9):3268–3273. [PubMed] [Google Scholar]
  24. Pierce G. B. Neoplasms, differentiations and mutations. Am J Pathol. 1974 Oct;77(1):103–118. [PMC free article] [PubMed] [Google Scholar]
  25. Pitot H. C., Barsness L., Goldsworthy T., Kitagawa T. Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature. 1978 Feb 2;271(5644):456–458. doi: 10.1038/271456a0. [DOI] [PubMed] [Google Scholar]
  26. Potter V. R. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer. 1978 Jul;38(1):1–23. doi: 10.1038/bjc.1978.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pugh T. D., Goldfarb S. Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res. 1978 Dec;38(12):4450–4457. [PubMed] [Google Scholar]
  28. ROE F. J., SALAMAN M. H., COHEN J. Incomplete carcinogens in cigarette smoke condensate: tumour-promotion by a phenolic fraction. Br J Cancer. 1959 Dec;13:623–633. doi: 10.1038/bjc.1959.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Redmond D. E., Jr Tobacco and cancer: the first clinical report, 1761. N Engl J Med. 1970 Jan 1;282(1):18–23. doi: 10.1056/NEJM197001012820105. [DOI] [PubMed] [Google Scholar]
  30. SALAMAN M. H., ROE F. J. Incomplete carcinogens: ethyl carbamate (urethane) as an initiator of skin tumour formation in the mouse. Br J Cancer. 1953 Dec;7(4):472–481. doi: 10.1038/bjc.1953.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Scherer E., Hoffmann M., Emmelot P., Friedrich-Freksa M. Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethylnitrosamine and partial hepatectomy. J Natl Cancer Inst. 1972 Jul;49(1):93–106. [PubMed] [Google Scholar]
  32. Sekas G., Owen W. G., Cook R. T. Fractionation and preliminary characterization of a low molecular weight bovine hepatic inhibitor of DNA synthesis in regenerating rat liver. Exp Cell Res. 1979 Aug;122(1):47–54. doi: 10.1016/0014-4827(79)90559-7. [DOI] [PubMed] [Google Scholar]
  33. Sivak A., Van Duuren B. L. Phenotypic expression of transformation: induction in cell culture by a phorbol ester. Science. 1967 Sep 22;157(3795):1443–1444. doi: 10.1126/science.157.3795.1443. [DOI] [PubMed] [Google Scholar]
  34. Sporn M. B., Newton D. L. Chemoprevention of cancer with retinoids. Fed Proc. 1979 Oct;38(11):2528–2534. [PubMed] [Google Scholar]
  35. Stack-Dunne M. P. Liver chalone: a review. Natl Cancer Inst Monogr. 1973 Jul;38:185–188. [PubMed] [Google Scholar]
  36. Teebor G. W., Becker F. F. Regression and persistence of hyperplastic hepatic nodules induced by N-2-Fluorenylacetamide and their relationship to hepatocarcinogenesis. Cancer Res. 1971 Jan;31(1):1–3. [PubMed] [Google Scholar]
  37. Verly W. G. The hepatic chalone. Natl Cancer Inst Monogr. 1973 Jul;38:175–184. [PubMed] [Google Scholar]
  38. WEISS P., KAVANAU J. L. A model of growth and growth control in mathematical terms. J Gen Physiol. 1957 Sep 20;41(1):1–47. doi: 10.1085/jgp.41.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Watanabe K., Williams G. M. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J Natl Cancer Inst. 1978 Nov;61(5):1311–1314. [PubMed] [Google Scholar]
  40. Williams G. M. Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Ann N Y Acad Sci. 1980;349:273–282. doi: 10.1111/j.1749-6632.1980.tb29532.x. [DOI] [PubMed] [Google Scholar]
  41. Williams G. M., Watanabe K. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen. J Natl Cancer Inst. 1978 Jul;61(1):113–121. doi: 10.1093/jnci/61.1.113. [DOI] [PubMed] [Google Scholar]
  42. Yotti L. P., Chang C. C., Trosko J. E. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science. 1979 Nov 30;206(4422):1089–1091. doi: 10.1126/science.493994. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES